BI-1230 is a potent inhibitor of HCV NS3 protease, exhibiting efficacy in the low nanomolar range, and notably suppresses viral replication. This compound demonstrates high selectivity, distinguishing effectively between other serine cysteine proteases. Additionally, BI-1230 exhibits favorable pharmacokinetic (PK) properties[1].